Figure 4
From: Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers
Serum TFF3 analysis in the chemotherapy group and correlation analysis between urine TFF3 and the GFR. (a) and (b) present an analysis of serum TFF3 levels in the PR, SD and PD groups of patients with gastric and colorectal cancer before and after chemotherapy, respectively. The significant ratios with P < 0.05 between 2 groups (before and after chemotherapy in the PR group of gastric and colorectal cancer). (c) and (d) present a correlation analysis between urine TFF3 levels and the GFR in patients with gastric and colorectal cancer, respectively. Urine TFF3 levels were significantly negatively correlated with the GFR in both the gastric and the colorectal cancer groups (P < 0.05).